AI summary by TwinMind

Mikkael Sekeres | When Blood Breaks Down: Life Lessons from Leukemia | Talks at Google

Talks at Google

55m 12s

Introduction and Background

  • Dr. Mikhail Sekris: Director of leukemia program at Cleveland Clinic, professor of medicine, vice chair for clinical research at Taussig Cancer Institute
  • Author of "When Blood Breaks Down: Life Lessons from Leukemia"
  • Writes regularly for New York Times Well section
  • Discussion topics: book, doctor-patient communication, cancer treatment changes during COVID-19

Writing Motivation and Medical Storytelling

  • Family background: father was journalist at Providence Journal (Rhode Island)
  • Medicine based on storytelling: patients tell illness stories to doctors/nurses who pass them to colleagues/trainees
  • Leukemia as "malignant golem" - terrible invader corrupting body's normal machinery
  • Inspiration from patients making impossible treatment choices with grace and dignity
  • Book chronicles real-life doctor-patient journeys through leukemia diagnosis

Leukemia Mechanics and Biology

  • Cancer = uncontrolled cell growth from genetic abnormalities (inherited or acquired)
  • Mutations give cells growth/survival advantage, prolonged lifespan
  • Bone marrow leukemia: cells fill narrow bone space ("high rent district"), normal cells die
  • Normal bone marrow produces: red blood cells (oxygen transport), white blood cells (infection fighting), platelets (bleeding control)
  • Paradox: sky-high white count (leukemia cells) but low red cells/platelets (normal cell death)
  • Acute leukemia: cells stuck in "eternal childhood" - immature, non-functional despite high counts

Book Structure and Patient Composites

  • Three main patient stories arriving within one day
  • Joan: 48-year-old surgical nurse, mother from Wooster, Ohio
  • David: 68-year-old factory worker, husband/father
  • Sarah: 36-year-old pregnant woman with leukemia diagnosis
  • All composites of real patients over nearly two decades
  • Every conversation, medical twist, life aspect actually occurred
  • Started with "point of tension" - gut feeling something doesn't feel right
  • David's tension: older adult choosing aggressive chemotherapy (4-6 weeks hospitalization, <10% cure chance) vs. less intensive therapy (0% cure, <5% death risk)
  • Sarah's tension: balancing treatment for herself vs. fetal effects
  • Joan's tension: treating rare acute leukemia with emerging Chinese treatments in real-time

Treatment Discoveries and Research History

  • Curative therapy from Chinese root discovery
  • Dog/beagle experiments leading to bone marrow transplantation
  • Brian Druker's research: focused on one drug for rare disease, lost job, eventually led to greatest leukemia therapy discovery

AI and Machine Learning in Medicine

  • Working with Aziz Nazi on AI approaches for leukemia
  • Pathologist agreement problem: only 75% agreement on bone marrow diagnoses
  • Local vs. expert pathologist disagreement: 25-40% of time
  • Machine learning applications:
    • Bone marrow snapshot analysis for diagnosis
    • Prognostic schemes incorporating genetic mutations (95% of leukemia patients have identifiable mutations)
    • Predicting drug response based on genetic mutation profiles
  • Moving from 1950s chromosome analysis (physical photo cutting) to sophisticated genetic mutation identification

Electronic Medical Records and Technology

  • "Workstations on wheels" (formerly "computers on wheels") - renamed to avoid patient offense
  • Mixed blessing of electronic medical records:
    • Positive: reduces chemotherapy errors through pre-built order sets with calculated doses
    • Negative: doctors staring at screens instead of patients, "pajama time" interference
    • Challenge: cut-and-paste culture eliminates thoughtful writing/processing of patient information
    • Research difficulties: Epic built as billing system, not research system, requires data dumping to "Clarity"
  • Number one physician dissatisfaction factor: electronic medical records and time spent in them

Risk Communication and Patient Decision-Making

  • Emergency room scenario: patient thinks they have flu, gets leukemia diagnosis, told "get affairs in order"
  • Complex information processing: explaining leukemia biology + treatment options within 24 hours
  • Treatment choice example: <20% cure chance with high death risk vs. 0% cure with <5% death risk
  • Emotional/family pressure: spouse and children influencing decisions
  • Staged information delivery: present information, let process, return with more
  • Patient coping mechanism: 75% remember best odds when asked about cure chances (said >50% when told <10%)
  • Bioethics question: true informed consent when patients misremember/reframe statistics?

Neurodivergent Patient Communication

  • Case: ~50-year-old man with intellectual capacity of 6-8 year old (oxygen deprivation at birth)
  • Jehovah's Witness beliefs: no blood products or risk hell
  • Mother as power of attorney helping decisions
  • Bioethics consultation involvement
  • Challenge: ensuring patient understanding of dying vs. preserving hope of someone mentally 6-8 years old
  • No clear answers in bioethics for these situations

COVID-19 Impact on Cancer Care

  • Dramatic drop in new cancer center patients during peak COVID
  • Fear: delayed diagnoses leading to more advanced cancer stages
  • Misdiagnosis case: leukemia patient with flu-like symptoms diagnosed as COVID, placed in quarantine, leukemia diagnosis delayed
  • Cancer patients with COVID: many times more likely to die (especially leukemia patients due to immune system dysfunction)
  • Advanced cancer patients choosing hospice over ICU when getting COVID
  • Healthcare settings implementing extreme safety precautions
  • Message: don't delay screening or symptom evaluation

Treatment Decision-Making and Specialization

  • Super narrow specialist focusing only on leukemia/related bone marrow cancers
  • Responsibility: know emerging treatments, participate in clinical trials, anticipate FDA approvals
  • Rarely surprised by new therapies due to specialization
  • Treatment timeline planning: therapy A now, therapy B in couple years, therapy C later
  • Incorporate new breakthrough treatments as soon as appropriate

Patient Reading: Mrs. Abrams Story

  • First day of internship in ICU with resident Dave
  • Mrs. Abrams: early 40s pediatrician with metastatic ovarian cancer
  • Chose not to be intubated, decided to die breathing on own
  • Children ages 10 and 8 said goodbye
  • Final night: writing birthday, holiday, graduation cards for next 10 years
  • Cards for every occasion so she could remain part of children's lives
  • Died writing cards all night with husband and friend helping
  • Pivotal moment leading to oncology career choice
  • Connection to people facing terrible cancers with dignity

Supporting Cancer Patients

  • Don't treat patients "like glass" - maintain normal interactions and teasing
  • Address elephant in room: ask about cancer or preference not to discuss
  • Avoid generic "anything you need, just ask"
  • Offer concrete help: specific dinner delivery days, transportation to appointments
  • Be deliberate about communication preferences and boundaries
  • Some want to discuss cancer constantly, others want safe zones without cancer talk

Screening and Prevention

  • Cancer screening complexity: designed to "overcatch" and over-diagnose
  • False positive likelihood higher than finding unknown cancer in asymptomatic people
  • US approach: discrete screening points vs. regular screening
  • Breast cancer example: 50% lifetime chance of false positive requiring further testing
  • Politics involved: organizations with vested interests advocate younger screening ages
  • US screening guidelines generally good but payment/access issues
  • Investment problem: screening benefits realized 10-20 years later, beyond current job tenure

COVID Vaccine and Leukemia Patients

  • Vaccine timeline prediction: second quarter 2021 availability, September 2021 herd immunity
  • "Needles in arms" challenge: development, manufacturing, distribution, convincing people
  • Most COVID vaccines are dead viruses (safe for leukemia patients) vs. live attenuated (dangerous)
  • Unknown: whether leukemia patients will develop immunity from vaccines
  • Plan: give vaccines when approved but maintain precautions due to uncertain effectiveness

Leukemia Cure Statistics and Outcomes

  • Adult acute leukemia cure rate: 30-40% (all comers)
  • Pediatric acute lymphoblastic leukemia: >90% cure rate (greatest cancer therapy success story)
  • Treatment protocol: 4-6 weeks hospitalization, then outpatient treatment
  • 6 months intensive chemotherapy, potentially 1.5-2 years lower dose maintenance
  • Cure definition: alive without leukemia 5 years post-diagnosis
  • Cured patients have essentially normal lifespans
  • Older adults face "competing risks" from other health conditions (heart disease, diabetes)
  • Once leukemia gone, it's gone permanently

TwinMind

Get summaries like this for your own meetings

TwinMind takes notes in the background during meetings, lectures, and calls, then writes the summary for you.

Free plan to get started

No bot joins your calls

Phone, desktop & Chrome apps

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome

Your next meeting, summarized like this

TwinMind listens in the background and turns meetings, lectures, and calls into searchable notes you can chat with. Start free.

Available on phone, desktop & Chrome